Stock ZEOX ZEO SCIENTIFIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Zeo ScientifiX, Inc.

Equities

ZEOX

US68621D2062

Market Closed - OTC Markets
Other stock markets
 19:56:27 28/06/2024 BST 		5-day change 1st Jan Change
1.923 USD +8.35% Intraday chart for Zeo ScientifiX, Inc. -22.45% +88.56%
06-14 Zeo ScientifiX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024 CI
06-03 Zeo Scientifix, Inc. Announces Management Changes CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Organicell Regenerative Medicine : Announces 1-for-200 Reverse Stock Split - Form 8-K
PU
Organicell Regenerative Medicine : Acquisition/Asset Disposal - Form 8-K
PU
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
AQ
ORGANICELL REGENERATIVE MEDICINE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
ORGANICELL REGENERATIVE MEDICINE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
OTCMKTS : OCEL 📋 Organicell Starts Enrolling Long COVID Trial 😷
EQ
Organicell Regenerative Medicine : Responds to Recent Promotional Activities Pursuant to OTC Markets Request - Form 8-K
PU
ORGANICELL REGENERATIVE MEDICINE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
OTCMKTS : $OCEL 📋 Organicell Activates COPD Trial at Mayo Clinic!
EQ
Can This Company’s Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?
EQ
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
EQ
ORGANICELL REGENERATIVE MEDICINE, INC. Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K/A)
AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZEOX Stock
  4. News Zeo ScientifiX, Inc.
  5. Press Releases